Benatar, M., Wuu, J., Andersen, P. M., Lombardi, V., & Malaspina, A. (2018). Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Annals of Neurology, 84(1), 130–139. https://doi.org/10.1002/ana.25276

Article  CAS  PubMed  Google Scholar 

Ceccanti, M., Pozzilli, V., Cambieri, C., Libonati, L., Onesti, E., Frasca, V., Fiorini, I., Petrucci, A., Garibaldi, M., Palma, E., Bendotti, C., Fabbrizio, P., Trolese, M. C., Nardo, G., & Inghilleri, M. (2020). Creatine kinase and progression rate in amyotrophic lateral sclerosis. Cells, 9(5), 1174. https://doi.org/10.3390/cells9051174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng, Y., Chen, Y., & Shang, H. (2021). Aberrations of biochemical indicators in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Translational Neurodegeneration, 10(1), 3. https://doi.org/10.1186/s40035-020-00228-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chio, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., Eurals Consortium. (2009). Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 10(5–6), 310–323. https://doi.org/10.3109/17482960802566824

Article  PubMed  Google Scholar 

Cohen, T. J., Waddell, D. S., Barrientos, T., Lu, Z., Feng, G., Cox, G. A., Bodine, S. C., & Yao, T.-P. (2007). The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. The Journal of Biological Chemistry, 282(46), 33752–33759. https://doi.org/10.1074/jbc.M706268200

Article  CAS  PubMed  Google Scholar 

de Andrade, H. M. T., de Albuquerque, M., Avansini, S. H., Rocha, Cd. S., Dogini, D. B., Nucci, A., Carvalho, B., Lopes-Cendes, I., & França, M. C. (2016). MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 368, 19–24. https://doi.org/10.1016/j.jns.2016.06.046

Article  CAS  PubMed  Google Scholar 

De Schaepdryver, M., Jeromin, A., Gille, B., Claeys, K. G., Herbst, V., Brix, B., Van Damme, P., & Poesen, K. (2018). Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 89(4), 367–373. https://doi.org/10.1136/jnnp-2017-316605

Article  PubMed  Google Scholar 

Dobrowolny, G., Martone, J., Lepore, E., Casola, I., Petrucci, A., Inghilleri, M., Morlando, M., Colantoni, A., Scicchitano, B. M., Calvo, A., Bisogni, G., Chiò, A., Sabatelli, M., Bozzoni, I., & Musarò, A. (2021). A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Discovery, 7(1), 4. https://doi.org/10.1038/s41420-020-00397-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elia, A. E., Lalli, S., Monsurrò, M. R., Sagnelli, A., Taiello, A. C., Reggiori, B., La Bella, V., Tedeschi, G., & Albanese, A. (2016). Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology, 23(1), 45–52. https://doi.org/10.1111/ene.12664

Article  CAS  PubMed  Google Scholar 

Feneberg, E., Oeckl, P., Steinacker, P., Verde, F., Barro, C., Van Damme, P., Gray, E., Grosskreutz, J., Jardel, C., Kuhle, J., & Koerner, S. (2018). Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology, 90(1), e22–e30. https://doi.org/10.1212/WNL.0000000000004761

Article  CAS  PubMed  Google Scholar 

Filipowicz, W., Jaskiewicz, L., Kolb, F. A., & Pillai, R. S. (2005). Post-transcriptional gene silencing by siRNAs and miRNAs. Current Opinion in Structural Biology, 15(3), 331–341. https://doi.org/10.1016/j.sbi.2005.05.006

Article  CAS  PubMed  Google Scholar 

Gille, B., De Schaepdryver, M., Goossens, J., Dedeene, L., De Vocht, J., Oldoni, E., Goris, A., Van Den Bosch, L., Depreitere, B., Claeys, K. G., Tournoy, J., Van Damme, P., & Poesen, K. (2019). Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology, 45(3), 291–304. https://doi.org/10.1111/nan.12511

Article  CAS  PubMed  Google Scholar 

Guo, Q.-F., Hu, W., Xu, L.-Q., Luo, H., Wang, N., & Zhang, Q.-J. (2021). Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology, 8(2), 448–455. https://doi.org/10.1002/acn3.51299

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovanda, A., Leonardis, L., Zidar, J., Koritnik, B., Dolenc-Groselj, L., Kovacic, S. R., Curk, T., & Rogelj, B. (2018). Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Scientific Reports, 8(1), 5609. https://doi.org/10.1038/s41598-018-23139-2

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Li, S., Ren, Y., Zhu, W., Yang, F., Zhang, X., & Huang, X. (2016). Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 367, 269–274. https://doi.org/10.1016/j.jns.2016.05.062

Article  CAS  PubMed  Google Scholar 

Li, X., Wang, H., Liu, Z., & Abudureyimu, A. (2021). CircSETD3 (Hsa_circ_0000567) suppresses hepatoblastoma pathogenesis via targeting the miR-423-3p/Bcl-2-interacting mediator of cell death axis. Frontiers in Genetics, 12, 724197. https://doi.org/10.3389/fgene.2021.724197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (san Diego, Calif.), 25(4), 402–408. https://doi.org/10.1006/meth.2001.1262

Article  CAS  PubMed  Google Scholar 

Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., Orrell, R., Howard, R., Talbot, K., Greensmith, L., Kuhle, J., Turner, M. R., & Malaspina, A. (2015). Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology, 84(22), 2247–2257. https://doi.org/10.1212/WNL.0000000000001642

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maia, L. F., Maceski, A., Conceição, I., Obici, L., Magalhães, R., Cortese, A., Leppert, D., Merlini, G., Kuhle, J., & Saraiva, M. J. (2020). Plasma neurofilament light chain: An early biomarker for hereditary ATTR amyloid polyneuropathy. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 27(2), 97–102. https://doi.org/10.1080/13506129.2019.1708716

Article  CAS  PubMed  Google Scholar 

Matus, S., Lopez, E., Valenzuela, V., Nassif, M., & Hetz, C. (2013). Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE, 8(7), e66672. https://doi.org/10.1371/journal.pone.0066672

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Petzold, A. (2005). Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss. Journal of the Neurological Sciences, 233(1–2), 183–198. https://doi.org/10.1016/j.jns.2005.03.015

Article  CAS  PubMed  Google Scholar 

Poesen, K., De Schaepdryver, M., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., Claeys, K. G., Couwelier, G., D’Hondt, A., Lamaire, N., Tilkin, P., Van Reijen, D., Gourmaud, S., Fedtke, N., Heiling, B., … Van Damme, P. (2017). Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology, 88(24), 2302–2309. https://doi.org/10.1212/WNL.0000000000004029

Article  CAS  PubMed  Google Scholar 

Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006). Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nature Neuroscience, 9(3), 408–419. https://doi.org/10.1038/nn1653

Article  CAS  PubMed  Google Scholar 

Quinlan, S., Kenny, A., Medina, M., Engel, T., & Jimenez-Mateos, E. M. (2017). MicroRNAs in neurodegenerative diseases. International Review of Cell and Molecular Biology, 334, 309–343. https://doi.org/10.1016/bs.ircmb.2017.04.002

Article  CAS  PubMed  Google Scholar 

Rafiq, M. K., Lee, E., Bradburn, M., McDermott, C. J., & Shaw, P. J. (2016). Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. European Journal of Neurology, 23(6), 1071–1078. https://doi.org/10.1111/ene.12995

Article  CAS  PubMed  Google Scholar 

Romano, A., Primiano, G., Antonini, G., Ceccanti, M., Fenu, S., Forcina, F., Gentile, L., Inghilleri, M., Leonardi, L., Manganelli, F., & Obici, L. (2024). Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? European Journal of Neurology, 31(1), e16070. https://doi.org/10.1111/ene.16070

Article  PubMed  Google Scholar 

Rowland, L. P., & Shneider, N. A. (2001). Amyotrophic lateral sclerosis. The New England Journal of Medicine, 344(22), 1688–1700. https://doi.org/10.1056/NEJM200105313442207

Article  CAS  PubMed  Google Scholar 

Saliminejad, K., KhorramKhorshid, H. R., SoleymaniFard, S., & Ghaffari, S. H. (2019). An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. Journal of Cellular Physiology, 234(5), 5451–5465. https://doi.org/10.1002/jcp.27486

Article  CAS  PubMed  Google Scholar 

Shefner, J., Heiman-Patterson, T., Pioro, E. P., Wiedau-Pazos, M., Liu, S., Zhang, J., Agnese, W., & Apple, S. (2020). Long-term edaravone efficacy in amyotrophic lateral sclerosis: Post-hoc analyses of Study 19 (MCI186-19). Muscle & Nerve, 61(2), 218–221. https://doi.org/10.1002/mus.26740

Article  CAS